Marinomed Granted European Patent for Antiviral Polymer
Dr Andreas Grassauer, CEO and co-founder of Marinomed, commented: “We are delighted that this first patent has been granted. This is the first of several patent applications that were filed in order to protect our intellectual property around products for the treatment of respiratory viruses.”
Most read news
Other news from the department research and development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.